Homicsko K - Search Results

1

Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.

Peters S, Bouchaab H, Zimmerman S, Bucher M, Gaide O, Letovanec I, Homicsko K, Michielin O. Peters S, et al. Among authors: homicsko k. Melanoma Res. 2014 Oct;24(5):496-500. doi: 10.1097/CMR.0000000000000055. Melanoma Res. 2014. PMID: 25185693

2

Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.

Zeng Q, Saghafinia S, Chryplewicz A, Fournier N, Christe L, Xie YQ, Guillot J, Yucel S, Li P, Galván JA, Karamitopoulou E, Zlobec I, Ataca D, Gallean F, Zhang P, Rodriguez-Calero JA, Rubin M, Tichet M, Homicsko K, Hanahan D. Zeng Q, et al. Among authors: homicsko k. Science. 2022 Nov 18;378(6621):eabl7207. doi: 10.1126/science.abl7207. Epub 2022 Nov 18. Science. 2022. PMID: 36395212

3

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8⁺ T cells and reprogramming macrophages.

Tichet M, Wullschleger S, Chryplewicz A, Fournier N, Marcone R, Kauzlaric A, Homicsko K, Deak LC, Umaña P, Klein C, Hanahan D. Tichet M, et al. Among authors: homicsko k. Immunity. 2023 Jan 10;56(1):162-179.e6. doi: 10.1016/j.immuni.2022.12.006. Immunity. 2023. PMID: 36630914 Free article.

4

Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion Analysis.

Liu YC, Ansaryan S, Tan J, Broguiere N, Lorenzo-Martín LF, Homicsko K, Coukos G, Lütolf MP, Altug H. Liu YC, et al. Among authors: homicsko k. Adv Sci (Weinh). 2024 Sep;11(34):e2401539. doi: 10.1002/advs.202401539. Epub 2024 Jun 24. Adv Sci (Weinh). 2024. PMID: 38924371 Free PMC article.

5

[Melanoma: a new therapeutic era].

Berthod G, Homicsko K, Bouchaab H, Matter M, Cerottini JP, Guggisberg D, Speiser D, Leyvraz S, Michielin O. Berthod G, et al. Among authors: homicsko k. Rev Med Suisse. 2011 May 25;7(296):1126-30. Rev Med Suisse. 2011. PMID: 21721201 Review. French.

6

[New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].

Moura B, Homicsko K, Berthod G, Cerottini JP, Guggisberg D, Gaide O, Maillard MH, Michielin O. Moura B, et al. Among authors: homicsko k. Rev Med Suisse. 2015 May 20;11(475):1108, 1110-4. Rev Med Suisse. 2015. PMID: 26152085 Review. French.

7

Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma.

Fankhauser M, Broggi MAS, Potin L, Bordry N, Jeanbart L, Lund AW, Da Costa E, Hauert S, Rincon-Restrepo M, Tremblay C, Cabello E, Homicsko K, Michielin O, Hanahan D, Speiser DE, Swartz MA. Fankhauser M, et al. Among authors: homicsko k. Sci Transl Med. 2017 Sep 13;9(407):eaal4712. doi: 10.1126/scitranslmed.aal4712. Sci Transl Med. 2017. PMID: 28904226 Clinical Trial.

8

Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.

Voruz S, Cairoli A, Naveiras O, de Leval L, Missiaglia E, Homicsko K, Michielin O, Blum S. Voruz S, et al. Among authors: homicsko k. Haematologica. 2018 Jan;103(1):e39-e41. doi: 10.3324/haematol.2017.179150. Epub 2017 Nov 2. Haematologica. 2018. PMID: 29097496 Free PMC article. No abstract available.

9

Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".

Voruz S, Martins F, Cairoli A, Naveiras O, Homicsko K, Missiaglia E, de Leval L, Bisig B, Michielin O, Blum S. Voruz S, et al. Among authors: homicsko k. Haematologica. 2018 Mar;103(3):e130. doi: 10.3324/haematol.2017.186932. Haematologica. 2018. PMID: 29491129 Free PMC article. No abstract available.

10

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

Cardoso E, Mercier T, Wagner AD, Homicsko K, Michielin O, Ellefsen-Lavoie K, Cagnon L, Diezi M, Buclin T, Widmer N, Csajka C, Decosterd L. Cardoso E, et al. Among authors: homicsko k. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:124-136. doi: 10.1016/j.jchromb.2018.02.008. Epub 2018 Feb 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 29544202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters